Although CD33 may also be expressed on normal monocytes and macrophages in healthy individuals, critically it is the MDSCs which represent the bulk of myeloid-cells in the cancer patients who would receive Gemtuzumab ozogamicin. The gene discussed is CD33; the disease is cancer.